CervoMed Inc. Proceeds from Notes Payable
CervoMed Inc. (CRVO) reported Proceeds from Notes Payable of $400.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2015-11-12
- CervoMed Inc. proceeds from notes payable for the quarter ending 2014-09-30 was $0.00.
- CervoMed Inc. proceeds from notes payable for the quarter ending 2014-06-30 was $0.00.
- CervoMed Inc. proceeds from notes payable for the quarter ending 2014-03-31 was $400.00K, a 100.00% increase year-over-year.
- CervoMed Inc. proceeds from notes payable for the quarter ending 2013-12-31 was $650.00K.
- CervoMed Inc. proceeds from notes payable for fiscal 2013 was $700.00K, a 79.90% decline from fiscal 2012.
- CervoMed Inc. proceeds from notes payable for fiscal 2012 was $3.48M, a 797.75% increase from fiscal 2011.
- CervoMed Inc. proceeds from notes payable for fiscal 2011 was $387.98K, a 1451.93% increase from fiscal 2010.
- CervoMed Inc. proceeds from notes payable for fiscal 2010 was $25.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $400.00K 10-Q · filed 2015-11-12 | $1.05M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $400.00K 10-Q · filed 2015-08-12 | $1.05M derived: sum of 3 quarters · filed 2015-08-12 | |
| 2014-03-31 | $400.00K 10-Q · filed 2015-05-11 | $1.05M derived: sum of 2 quarters · filed 2015-05-11 | ||
| 2013-12-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $700.00K 10-K · filed 2015-04-03 | ||
| 2013-09-30 | $50.00K 10-Q · filed 2014-11-12 | |||
| 2013-03-31 | $200.00K 10-Q · filed 2014-05-20 | |||
| 2012-12-31 | $3.48M 10-K/A · filed 2013-04-24 | |||
| 2011-12-31 | $387.98K 10-K/A · filed 2013-04-24 | |||
| 2010-12-31 | $25.00K 10-K · filed 2012-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |